Anthropic宣布其湾区生物实验室通过AI模型发现了一个具有类似CRISPR特性的新酶系统，该系统能够进行DNA切割、复制和粘贴操作。1根据Anthropic CEO Dario Amodei的说法，这一发现主要由Claude AI在21小时内完成，期间使用了约950个代理和2.1亿个tokens。1
该生物实验室于今年春季建立，目前所有实验工作均由人类科学家执行，仅涉及低生物安全风险等级（BSL-1和BSL-2）的研究。1Amodei表示，虽然"最终可能会由Claude自己安全地执行实验"，但目前尚未采取这样的步骤。1
Anthropic has revealed that its biology laboratory in the Bay Area has identified a previously unknown enzyme system with CRISPR-like properties, capable of cutting, copying, and pasting DNA sequences.1 The discovery was primarily conducted by Claude, the company's AI model, which completed the research in 21 hours using approximately 950 agents and 210 million tokens.1 CEO Dario Amodei highlighted this achievement as a significant milestone for the company's foray into biological research.
The biology laboratory was established by Anthropic in the spring of this year.1 All experimental work is currently performed by human scientists, and operations are limited to low biosafety risk levels (BSL-1 and BSL-2) with no involvement of human-infectious pathogens.1 Amodei indicated that Claude may eventually be capable of safely executing experiments independently in the future, though this has not yet occurred.1 The executive previously stated that artificial intelligence could cure most diseases within five to ten years.1
评论
还没有评论，欢迎留下第一条。